John Wesner

John is the Director of the Process Development team at GentiBio. John has worked in multiple positions and companies across his 20+ years in the industry, including roles in Biologics Manufacturing at GlaxoSmithKline, biologics process development at Janssen (J&J) Pharmaceuticals, and cell therapy process development at Dendron and Juno Therapeutics. His work at Juno developing and refining the Breyanzi CAR-T cell therapy manufacturing process was critical for the successful commercialization of this life-saving product. In his most recent role at Bristol Meyers Squibb, John led a Global Manufacturing Sciences and Technology lab team supporting two commercial CAR-T products. Northeast Philadelphia born and raised, John obtained a BA in Biology from Holy Family University and an MS in Biotechnology from the University of Pennsylvania.